Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ballentine

Showing results (71-80 of 451) with videos related to

Pageof 46
Sort By:
Urologic Oncology|November 3, 2009
Limitations and use of PSA derivatives in the screening and risk stratification of prostate cancerStacy Loeb, H Ballentine Carter
Physical Review. B, Condensed Matter|May 15, 1990
Experimental probe for thin-film magnetism in p(1 x 1) Pd and V on Ag(100)Fink, Ballentine, Erskine, et al.
Human Psychopharmacology|December 20, 2023
Trajectories of sentiment in 11,816 psychoactive narrativesSam Freesun Friedman, Galen Ballentine
Journal of Palliative Medicine|April 1, 2016
Physician-Assisted Death Does Not Improve End-of-Life CareJennifer Ballentine, Cordt Kassner, Ira Byock
Journal of the National Comprehensive Cancer Network : JNCCN|August 19, 2007
Update on PSA testingMark L Gonzalgo, H Ballentine Carter
Journal of the National Cancer Institute|June 3, 2004
Improved biomarkers for prostate cancer: a definite needH Ballentine Carter, William B Isaacs
Current Opinion in Urology|April 8, 2004
Update on watchful waiting for prostate cancerMohamad E Allaf, H Ballentine Carter
The Biological Bulletin|May 11, 2023
Locomotory Palp Function in Interstitial AnnelidsWill M Ballentine, Kelly M Dorgan
The Journal of Urology|September 27, 2017
Patients with Intermediate Risk Prostate Cancer May be Good Candidates for Active Surveillance: ConJeffrey J Tosoian, H Ballentine Carter
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Active Surveillance of Localized Prostate Cancer: Acknowledging UncertaintyJeffrey J Tosoian, H Ballentine Carter
Pageof 46

Showing results (71-80 of 451) with videos related to

Sort By:
Pageof 46
Urologic Oncology|November 3, 2009
Limitations and use of PSA derivatives in the screening and risk stratification of prostate cancerStacy Loeb, H Ballentine Carter
Physical Review. B, Condensed Matter|May 15, 1990
Experimental probe for thin-film magnetism in p(1 x 1) Pd and V on Ag(100)Fink, Ballentine, Erskine, et al.
Human Psychopharmacology|December 20, 2023
Trajectories of sentiment in 11,816 psychoactive narrativesSam Freesun Friedman, Galen Ballentine
Journal of Palliative Medicine|April 1, 2016
Physician-Assisted Death Does Not Improve End-of-Life CareJennifer Ballentine, Cordt Kassner, Ira Byock
Journal of the National Comprehensive Cancer Network : JNCCN|August 19, 2007
Update on PSA testingMark L Gonzalgo, H Ballentine Carter
Journal of the National Cancer Institute|June 3, 2004
Improved biomarkers for prostate cancer: a definite needH Ballentine Carter, William B Isaacs
Current Opinion in Urology|April 8, 2004
Update on watchful waiting for prostate cancerMohamad E Allaf, H Ballentine Carter
The Biological Bulletin|May 11, 2023
Locomotory Palp Function in Interstitial AnnelidsWill M Ballentine, Kelly M Dorgan
The Journal of Urology|September 27, 2017
Patients with Intermediate Risk Prostate Cancer May be Good Candidates for Active Surveillance: ConJeffrey J Tosoian, H Ballentine Carter
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Active Surveillance of Localized Prostate Cancer: Acknowledging UncertaintyJeffrey J Tosoian, H Ballentine Carter
Pageof 46